Literature DB >> 11667929

Linezolid and reversible myelosuppression.

P A Abena, V G Mathieux, J M Scheiff, L M Michaux, B C Vandercam.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11667929

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

Review 1.  Drug-induced myelosuppression : diagnosis and management.

Authors:  Peter J Carey
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

2.  Linezolid induces ring sideroblasts.

Authors:  Christophe Willekens; Florent Dumezy; Thomas Boyer; Aline Renneville; Julien Rossignol; Céline Berthon; Angélique Cotteau-Leroy; Lotfi Mehiaoui; Bruno Quesnel; Claude Preudhomme
Journal:  Haematologica       Date:  2013-11       Impact factor: 9.941

3.  Systematic review and meta-analysis of the efficacy and safety of therapy with linezolid containing regimens in the treatment of multidrug-resistant and extensively drug-resistant tuberculosis.

Authors:  Xin Zhang; Matthew E Falagas; Konstantinos Z Vardakas; Rui Wang; Rong Qin; Jin Wang; Youning Liu
Journal:  J Thorac Dis       Date:  2015-04       Impact factor: 2.895

4.  The Oxazolidinones.

Authors:  Gerald A. Evans
Journal:  Curr Infect Dis Rep       Date:  2002-02       Impact factor: 3.725
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.